Altamira Therapeutics Ltd. Current Assets
Altamira Therapeutics Ltd. (CYTOF) had Current Assets of $247.57 thousand as of 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Notes
ifrs-full:CurrentAssets · last filed 2025-08-29
- 2023-12-31: Current Assets 1.22M CHF.
- 2023-06-30: Current Assets 1.73M CHF.
- 2022-12-31: Current Assets 1.77M CHF.
- 2022-06-30: Current Assets 1.93M CHF.
CHF
| Period end | Current Assets | Current Assets as first filed |
|---|---|---|
| 2023-12-31 | 1.22M CHF 20-F/A · filed 2024-04-22 | |
| 2023-06-30 | 1.73M CHF 6-K · filed 2023-09-12 | |
| 2022-12-31 | 1.77M CHF 20-F/A · filed 2024-04-22 | |
| 2022-06-30 | 1.93M CHF 6-K/A · filed 2023-08-21 | |
| 2021-12-31 | 4.09M CHF 6-K/A · filed 2023-08-21 | 3.76M CHF 20-F · filed 2022-04-12 |
| 2021-06-30 | 9.15M CHF 6-K · filed 2021-09-08 | |
| 2020-12-31 | 11.62M CHF 20-F · filed 2022-04-12 | |
| 2020-06-30 | 389.80K CHF 6-K/A · filed 2020-09-17 | |
| 2019-12-31 | 2.37M CHF 20-F · filed 2021-03-31 | |
| 2019-06-30 | 6.32M CHF 6-K · filed 2019-08-15 | |
| 2018-12-31 | 6.06M CHF 20-F · filed 2020-04-16 | |
| 2017-12-31 | 15.87M CHF 20-F · filed 2019-03-14 | |
| 2016-12-31 | 33.69M CHF 20-F · filed 2018-03-22 |
USD
| Period end | Current Assets |
|---|---|
| 2025-06-30 | $247.57K 6-K · filed 2025-08-29 |
| 2024-12-31 | $1.54M 6-K · filed 2025-08-29 |
| 2024-06-30 | $524.01K 6-K · filed 2024-09-24 |
| 2023-12-31 | $1.45M 20-F · filed 2025-04-30 |
| 2023-01-01 | $1.91M 20-F · filed 2025-04-30 |